Trading involves risk
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trading involves risk
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
English (International)
West Pharmaceutical Services Inc
Closed
SectorHealthcare
222.47 1.67
Overview
Share price change
24h
Min
221.62
Max
224.25
Income | -40M 90M |
|---|---|
Sales | -51M 698M |
P/E Sector Avg | 34.349 40.527 |
EPS | 1.45 |
Dividend yield | 0.38 |
Profit margin | 12.865 |
Employees | 10,600 |
EBITDA | -54M 151M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +24.69% upside |
Dividend yield Sector Avg | 0.38% 2.40% |
|---|---|
Next Earnings | 24 Jul 2025 |
Next Dividend date | 6 Aug 2025 |
Next Ex Dividend date | 30 Jul 2025 |
Market Cap | 370M 16B |
|---|---|
Previous open | 220.8 |
Previous close | 222.47 |
News Sentiment
By Acuity
50%
50%
146 / 375 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
West Pharmaceutical Services Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
West Pharmaceutical Services Inc Forecast
Price Target
By TipRanks
24.69% upside
12 Months Forecast
Average 275.83 USD 24.69%
High 325 USD
Low 245 USD
Based on 8 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.
Sentiment
By Acuity
146 / 375 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
